Altimmune, Inc. — Director's Dealing 2022

Feb 14, 2022

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Altimmune, Inc. (ALT)
CIK: 0001326190
Period of Report: 2021-12-31

Reporting Person: GILL JOHN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-03	Common Stock, par value $0.0001	G	3000	—	Disposed	8199	Direct
2021-12-27	Common Stock, par value $0.0001	G	2714	—	Disposed	5485	Direct
2021-12-27	Common Stock, par value $0.0001	G	2714	—	Disposed	2771	Direct

Footnotes

F1: This transaction was a bona fide gift of common stock made on May 3, 2021.

F2: This transaction was a bona fide gift of common stock made on December 27, 2021.